The test, created by Des Plaines, Ill.-based Abbott Molecular, is designed to distinguish between the hepatitis C virus genotypes 1, 1a, 1b, 2, 3, 4 and 5. The test is expected to help improve patient outcomes by helping physicians to indentify the type of hepatitis C a patient has and choose the appropriate drug therapy.
More Articles on Gastroenterology:
International Surgery Journal Appoints Dr. Rajiv Datta to Editorial Board
Polyclinic Surgery Center Selects ProVation Medical Software
12 Statistics on GI Revenue per Case by Geographic Location
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
